Hong Kong

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Hepatitis B3 trials

Phase

• Phase 22 trials
• Phase 1/21 trial

Status

• Completed3 trials

Lead sponsor

• Vir Biotechnology, Inc.3 trials

Closed trials

• Completed

  A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection

  NCT05612581· Phase 1/2· Vir Biotechnology, Inc.· Source

• Completed

  Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

  NCT04856085· Phase 2· Vir Biotechnology, Inc.· Source

• Completed

  Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

  NCT04412863· Phase 2· Vir Biotechnology, Inc.· Source